References
- Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005;24(10):1455–1481. doi: 10.1002/sim.2022
- Vilakati S, Cortese G. Estimating survival distributions for time-varying smart designs. South Afr Stat J. 2019;53(2):15–131.
- Guo X, Tsiatis A. A weighted risk set estimator for survival distributions in two-stage randomization designs with censored survival data. Int J Biostat. 2005;1(1):1–15. doi: 10.2202/1557-4679.1000
- Kidwell KM, Wahed AS. Weighted log-rank statistic to compare shared-path adaptive treatment strategies. Biostatistics. 2013;14(2):299–312. doi: 10.1093/biostatistics/kxs042
- Kolitz JE, George SL, Benson DM, et al. Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from CALG 19808. Cancer. 2014;120(7):1010–1017. doi: 10.1002/cncr.28516
- Kolitz JE, George SL, Marcucci G, et al. P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. Blood. 2010;116(9):1413–1421. doi: 10.1182/blood-2009-07-229492
- Klein JP, Logan B, Harhoff M, et al. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):4505–4519. doi: 10.1002/sim.2864
- Lin X, Xu Q. A new method for the comparison of survival distributions. Pharm Stat. 2010;9(1):67–76. doi: 10.1002/pst.376
- Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol. 1974;66(5):688. doi: 10.1037/h0037350
- Li H, Han D, Hou Y, et al. Statistical inference methods for two crossing survival curves: a comparison of methods. PLoS One. 2015;10(1):e0116774. doi: 10.1371/journal.pone.0116774